Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in fou...
QFII increased its holdings in 114 stocks in the third quarter, with 37 stocks doubling in value this year
BO YUAN released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 22.41%
A-share chemical raw material stocks generally fell, with CXPC dropping over 8%
BO YUAN: The subsequent commercialization process of lithium iodide still requires customer validation, and there is still uncertainty in forming large-scale market sales
BO YUAN: Iodide products have not yet achieved sales in the solid-state battery field
BO YUAN has completed the absorption and merger of its wholly-owned subsidiary